Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

TPEX:4747 Revenue

Johnson Chemical Pharmaceutical Works had revenue of 146.59M TWD in the quarter ending March 31, 2026, a decrease of -0.14%. This brings the company's revenue in the last twelve months to 569.57M, down -4.28% year-over-year. In the year 2025, Johnson Chemical Pharmaceutical Works had annual revenue of 569.77M, down -6.81%.

• Revenue (ttm): 569.57M
• Revenue Growth: -4.28%
• P/S Ratio: 4.54
• Revenue / Employee: 3.31M
• Employees: 172
• Market Cap: 2.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	569.77M	-41.64M	-6.81%
Dec 31, 2024	611.42M	4.70M	0.78%
Dec 31, 2023	606.71M	112.04M	22.65%
Dec 31, 2022	494.67M	83.18M	20.21%
Dec 31, 2021	411.49M	-12.52M	-2.95%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error